Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 198.30
-8.22 (-3.98%)
Oct 1, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 263.15 billion as of October 1, 2026. Its market cap has increased by 3.67% in one year.
Market Cap
263.15B
Enterprise Value
306.72B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
198.30
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 263.15B, an increase of 16.06%. That is a compound annual growth rate of 3.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 263.15B | 15.08% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 493.20B |
| Ipca Laboratories | 491.70B |
| Ajanta Pharma | 444.46B |
| Emcure Pharmaceuticals | 368.55B |
| Wockhardt | 343.88B |
| Cohance Lifesciences | 175.18B |
| Alembic Pharmaceuticals | 169.34B |
| Alivus Life Sciences | 166.53B |